Certara Narrows 2026 Growth Range After Software Rebound

The Tip Desk · November 11, 2026 · 3 min read

Software revenue was $48.8 million, up 11% from a year earlier, the first double-digit software quarter in two years.

Certara, Inc. (CERT), a global leader in model-informed drug development, reported third-quarter 2026 revenue of $94.9 million, up 4% from $90.9 million a year earlier, after 1% growth in the second quarter.

Software revenue was $48.8 million, up 11% from $43.8 million a year earlier, the first double-digit software quarter in two years, after 4% growth in the prior quarter. Chief Executive Officer Jon Resnick said software revenue grew 11% organically. Services revenue was $46.1 million, down 2% from $47.1 million a year earlier, after a 3% decline in the second quarter.

The company said results of the Regulatory and Medical Writing business are reported as discontinued operations after a May 8, 2026 divestiture, and the discussion excludes that business for all periods presented.

Adjusted EBITDA was $30.2 million, up 6% from $28.6 million a year earlier, after a 3% decline in the second quarter. Adjusted EBITDA margin was 31.8%, up more than 370 basis points from the second quarter, according to Interim Chief Financial Officer Faiz Mohammed, who said the quarter reflected continued software momentum and initial benefits of operating actions implemented in the first half. Net loss from continuing operations narrowed to $3.6 million from $4.8 million a year earlier. Diluted loss from continuing operations was $0.02 a share, compared with $0.03 a year earlier.

Total bookings were $92.5 million, up 4% from $88.6 million a year earlier. Software bookings were $46.9 million, up 15% from $40.8 million a year earlier. Services bookings were $45.6 million, down 5% from $47.8 million a year earlier. Trailing twelve-month total bookings were $409.2 million, up 2%; trailing twelve-month software bookings were $202.4 million, up 8%. Trailing twelve-month services bookings were $206.8 million, down 2%, with a trailing twelve-month services book-to-bill of 1.15.

Cost of revenues fell to $31.4 million from $33.4 million a year earlier, primarily due to a $1.6 million decrease in equity-based compensation. Operating expenses rose to $61.1 million from $58.1 million a year earlier, including a $4.4 million increase in employee-related costs and a $1.2 million increase in executive recruiting expenses. Adjusted net income was $13.5 million, down $0.3 million from $13.8 million a year earlier; adjusted diluted earnings were $0.09 a share, unchanged.

Cash from continuing operations was $30.7 million in the quarter, and cash ended at $214.9 million. Grant Peterson was appointed Chief Product Officer effective November 2, 2026.

With nine months of results reported, Certara narrowed its 2026 full-year revenue growth range to 2% to 3%, from the 0% to 4% range reaffirmed after the second quarter. The company continues to expect software revenue growth to be above that range and services revenue growth to be at or below the low end of that range as it works to convert its pipeline into bookings and revenue. The previously communicated full-year 2026 adjusted EBITDA margin outlook of 29% to 31% was left unchanged as appropriate for the fourth quarter. Full-year 2026 adjusted diluted earnings per share were updated to $0.31 to $0.34.